695215-94-2

Basic information

• Product Name: 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester
• Synonyms: 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester;1-Methyl 5-[methyl(methylsulphonyl)amino]isophthalate, N-[3-Carboxy-5-(methoxycarbonyl)phenyl]-N-methylmethanesulphonamide;3-(methoxycarbonyl)-5-(N-methylmethylsulfonamido)benzoic acid
• CAS NO: 695215-94-2
• Molecular Formula: C₁₁H₁₃NO₆S
• Molecular Weight: 287.28902
• Mol File: 695215-94-2.mol
• Article Data: 20

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester(695215-94-2)
• EPA Substance Registry System: 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester(695215-94-2)

Safety Data

• Hazardous Substances Data: 695215-94-2(Hazardous Substances Data)

Usage

General Description

The chemical "1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-, MonoMethyl ester" is a compound derived from benzenedicarboxylic acid, commonly known as phthalic acid. Its chemical structure includes a methyl ester group and a methylsulfonyl amino group attached to the benzene ring. 1,3-Benzenedicarboxylic acid, 5-[Methyl(Methylsulfonyl)aMino]-,MonoMethyl ester has various industrial applications, including its use as a plasticizer in the production of polyvinyl chloride (PVC) and other polymers. It is also used in the synthesis of pharmaceuticals and agrochemicals. Additionally, it is known for its potential as a reactive diluent in epoxy resins and as a component in adhesives and sealants.

Upstream product

• 62814-45-3 5-methanesulphonylamino-isophthalic acid dimethyl ester 
• 99-27-4 dimethyl 5-aminoisophthalate 
• 695215-93-1 dimethyl-5-[methyl(methylsulfonyl)amino]isophthalate 

Downstream Products

• 1026044-87-0 C₁₇H₂₁N₃O₆S 
• 1026070-16-5 C₁₈H₂₃N₃O₆S 
• 1026335-17-0 C₁₄H₂₀N₂O₅S 
• 1026309-20-5 C₁₉H₂₂N₂O₆S 
• 1026325-50-7 C₁₈H₂₀N₂O₅S 
• 940879-51-6 3-(N-methylmethan-5-ylsulfonamido)-5-(propylcarbamoyl)benzoic acid 
• 940879-52-7 3-{[(2,5-dimethyloxazol-4-yl)methyl]carbamoyl}-5-(N-methylmethan-5-ylsulfonamido)benzoic acid 
• 940879-53-8 3-(benzylcarbamoyl)-5-(N-methylmethan-5-ylsulfonamido)benzoic acid 
• 940879-54-9 (S)-3-(N-methylmethan-5-ylsulfonamido)-5-((1-phenylethyl)carbamoyl)benzoic acid 
• 940879-55-0 (S)-3-[(2-hydroxy-1-phenylethyl)carbamoyl]-5-(N-methylmethan-5-ylsulfonamido)benzoic acid 
• 940879-56-1 3-{[1-(2,5-dimethyloxazol-4-yl)ethyl]carbamoyl}-5-(N-methylmethan-5-ylsulfonamido)benzoic acid 
• 1026742-93-7 C₃₇H₆₇N₅O₇SSi 
• 1026742-99-3 C₄₀H₆₈N₆O₈SSi 
• 1026510-06-4 C₄₁H₆₇N₅O₇SSi 

Relevant articles and documents

Cyanobacterial peptides as a prototype for the design of potent β-secretase inhibitors and the development of selective chemical probes for other aspartic proteases

Inspired by marine cyanobacterial natural products, we synthesized modified peptides with a central statine-core unit, characteristic for aspartic protease inhibition. A series of tasiamide B analogues inhibited BACE1, a therapeutic target in Alzheimer's

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The invention relates to substituted 1,2-ethylenediamines of general formula (I), wherein the radicals R1-R13, A, B, L and i are as defined in the description and the claims. The invention also relates to the use thereof for treating Alzheimer's disease (AD) and similar diseases.

ASPARTYL PROTEASE INHIBITORS

The invention provides compounds of the formula (I) N-oxides, addition salts, quaternary amines, metal complexes, stereochemically isomeric forms and metabolites thereof, wherein G is-O-, -S(=O)r-, -CRdRd or -NRa-; W is H, C1-C6